INSIGHTS ON SOLID DOSE MANUFACTURING

• Segments: Next-Generation Tablet Press Technology

  Segments increase press output by up to 25% and cut setup time by 88%. Learn the benefits, drawbacks, and manufacturing needs of this rapidly growing tablet press technology.

• Overload Setting – Tricks And Techniques

  Learn how a partner company that is committed to assisting manufacturers with calibration and optimal set-point establishment can serve as a valuable resource in achieving optimal tablet production.

• 5 Hidden Risks In Early-Phase OSD Formulation Development

  Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.

• Optimizing DPI Production: Filling Technologies For Precision And Performance

  Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.

• How High Drug Load Nanocrystalline Tablets Lower Pill Burden

  3/12/2025

  We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.

• Advances In Oral GLP-1 Analogs For Obesity

  9/12/2024

  Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.

• Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling

  7/15/2026

  Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.

• Combining Powdose® And Diffucaps® For Precise Solid Oral Dosing

  6/30/2025

  Combining POWDOSE® and Diffucaps® enables precise, individualized solid oral dosing—improving drug delivery, patient compliance, and therapeutic outcomes in personalized medicine applications.

• Enabling Complex Phase IIa Dosing Through Flexible Clinical Packaging Design

  5/6/2026

  Discover how flexible, patient‑centric clinical packaging supports complex Phase IIa dosing while protecting timelines, ensuring compliance, and avoiding costly primary packaging changes.